PODD
HEALTHCAREInsulet Corporation
$151.28-16.25 (-9.70%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving PODD Today?
No stock-specific AI insight has been generated for PODD yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$148.31$354.88
$151.28
Fundamentals
Market Cap$10.5B
P/E Ratio43.5
EPS$3.48
Dividend Yield—
Dividend / Share—
ROE0.2%
Profit Margin0.1%
Debt / Equity—
Trading
Volume4.5M
Avg Volume (10D)—
Shares Outstanding69.3M
PODD News
29 articles- Insulet (PODD) Is Down 6.8% After Raising 2026 Guidance And Advancing Closed‑Loop Trial - What's ChangedSimply Wall Street·May 9, 2026
- Insulet Corp (PODD) Shares Fall 3.8% -- What GF Score of 83 Tells InvestorsGuruFocus·May 9, 2026
- PODD Maintained by Barclays -- Price Target Lowered to $198GuruFocus·May 8, 2026
- Insulet Trial Targets Type 2 Diabetes As Shares Trade Below EstimatesYahoo Finance·May 8, 2026
- PODD Maintained by Bernstein -- Price Target Lowered to $200GuruFocus·May 7, 2026
- Insulet jumps as Q1 results top guidance and full-year outlook risesQuiver Quantitative·May 7, 2026
- Insulet Corporation (NASDAQ:PODD) Q1 2026 Earnings Call TranscriptInsider Monkey·May 7, 2026
- Insulet Corporation (PODD) PT Lowered to $200 at Bernstein SocGen Group, 'shares fall; what now?'StreetInsider·May 7, 2026
- Insulet Q1 Earnings Call HighlightsMarketbeat·May 6, 2026
- Why This Stock Sold Off Despite Its 'Dominant' First-Quarter ReportYahoo Finance·May 6, 2026
- Insulet Corporation Q1 2026 Earnings Call SummaryMoby·May 6, 2026
- Insulet (PODD) Loses 17.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerYahoo Finance·May 6, 2026
- Insulet (PODD) Q1 Earnings and Revenues Top EstimatesYahoo Finance·May 6, 2026
- Insulet (NASDAQ:PODD) Reports Upbeat Q1 CY2026, Stock SoarsYahoo Finance·May 6, 2026
- Insulet raises revenue expectations for 2026Medtechdive·May 6, 2026
- Insulet Reports First Quarter 2026 ResultsYahoo Finance·May 6, 2026
- Insulet Unveils 2025 Sustainability Report Highlighting Strong Momentum Across Key PrioritiesYahoo Finance·May 5, 2026
- Evolus, Inc. (EOLS) Reports Q1 Loss, Tops Revenue EstimatesYahoo Finance·May 4, 2026
- Insulet (PODD) is an Incredible Growth Stock: 3 Reasons WhyYahoo Finance·May 4, 2026
- Insulet (PODD) Upgraded to Buy: Here's WhyYahoo Finance·May 4, 2026
- Insulet Initiates EVOLVE Pivotal Study to Advance Fully Closed-Loop Automated Insulin Delivery System for Type 2 DiabetesYahoo Finance·May 4, 2026
- Why Insulet (PODD) Is Down 7.7% After FDA Class I Omnipod 5 Recall Expansion - And What's NextYahoo Finance·May 3, 2026
- Rothschild & Co Redburn Downgrades Insulet Corporation (PODD), Cites “Eroding” Product Moats and DistributionYahoo Finance·May 1, 2026
- PAHC vs. PODD: Which Stock Is the Better Value Option?Yahoo Finance·Apr 30, 2026
- FDA Flags High-Risk Recall Of Insulet's Omnipod 5 Pods Over Insulin Delivery ConcernsBenzinga·Apr 29, 2026
- Insulet (PODD) Ends April With Strong Analyst Sentiment Amid Strong Earnings ExpectationsYahoo Finance·Apr 29, 2026
- 1 Oversold Stock Primed to Rebound and 2 We IgnoreYahoo Finance·Apr 29, 2026
- Insulet to Participate in BofA Securities 2026 Health Care ConferenceYahoo Finance·Apr 28, 2026
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GoHealth Inc. - GOCOGlobeNewswire Inc.·Apr 21, 2026
All 29 articles loaded
Price Data
Open$167.04
Previous Close$167.53
Day High$168.59
Day Low$148.31
52 Week High$354.88
52 Week Low$148.31
52-Week Range
$148.31$354.88
$151.28
Fundamentals
Market Cap$10.5B
P/E Ratio43.5
EPS$3.48
Dividend Yield—
Dividend / Share—
ROE0.2%
Profit Margin0.1%
Debt / Equity—
Trading
Volume4.5M
Avg Volume (10D)—
Shares Outstanding69.3M
About Insulet Corporation
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company is headquartered in Acton, Massachusetts.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—